Literature DB >> 15161865

Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.

Yue Ming1, Peep V Algvere, Anne Odergren, Lennart Berglin, Ingeborg van der Ploeg, Stefan Seregard, Anders Kvanta.   

Abstract

PURPOSE: Transpupillary thermotherapy (TTT) is currently being evaluated for treatment of choroidal neovascularization (CNV) in age-related macular degeneration. To optimize TTT for CNV, the effect was analyzed of invisible (subthreshold) or visible (threshold) doses of TTT on the normal mouse retina and on experimental CNV.
METHODS: TTT was delivered to the normal retina of 42 mice with a diode laser at increasing power settings (50, 60, 70, or 80 mW), to obtain thermal lesions ranging from invisible (subthreshold) to visible (threshold) burns. CNV was induced in 53 mice by krypton laser photocoagulation of the fundus, after which the CNV lesions were treated with TTT (50, 60, or 80 mW). Eyes were enucleated 7 days after TTT and prepared for histology, and the CNV complex was evaluated on hematoxylin-eosin stained serial sections by measuring the maximum height of the CNV lesions. Ultrastructural changes were examined by transmission electron microscopy.
RESULTS: Increasing the TTT laser power yielded gradually more visible effects. At 50 mW, which induced subthreshold burns, no damage was seen in the neural retina, retinal pigment epithelium (RPE), or choroid at any time point. By contrast, eyes treated with higher power exhibited progressively more damage to the neural retina, including a complete disruption of the outer nuclear layer. When TTT was applied to the laser-induced CNV lesions, the height of lesions was significantly reduced (P < 0.001) in response to all three power settings at 7 days after treatment. The mean relative thickness of the CNV lesion was 3.29 +/- 0.89 in untreated mice, whereas in TTT-treated mice it was 1.69 +/- 0.35, 1.69 +/- 0.41 and 1.70 +/- 0.17 at power settings of 50, 60, and 80 mW, respectively. The overlying neural retina showed no apparent damage with the 50- or 60-mW settings, whereas outer nuclear layer disruption occurred with a power of 80 mW. Electron microscopy confirmed the presence of vascular occlusion at 1 day and a fibrotic scar at 7 days after TTT.
CONCLUSIONS: Subthreshold TTT can effectively occlude newly formed vessels and cause regression of the experimental CNV complex without damaging the neural retina. The results demonstrate the importance of using subthreshold laser power in experimental and clinical evaluation of TTT.

Entities:  

Mesh:

Year:  2004        PMID: 15161865     DOI: 10.1167/iovs.03-1329

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice.

Authors:  Shigeru Honda; Takayuki Nagai; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-02       Impact factor: 3.117

2.  Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors:  Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

3.  Objective area measurement technique for choroidal neovascularization from fluorescein angiography.

Authors:  Micah J Guthrie; Christian R Osswald; Nicole L Valio; William F Mieler; Jennifer J Kang-Mieler
Journal:  Microvasc Res       Date:  2013-12-05       Impact factor: 3.514

4.  Subthreshold transpupillary thermotherapy of the retina and experimental choroidal neovascularization in a rat model.

Authors:  Haicheng She; Xiaoxin Li; Wenzhen Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-21       Impact factor: 3.117

5.  Relationship between intensity of reflected light and temperature increase: assessment of fundus pigmentation for transpupillary thermotherapy.

Authors:  Ryo Obata; Yasuhiro Tamaki; Yasuo Yanagi; Junko Kami
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

6.  Heparanase-1 activities in the development of laser induced choroidal neovascularization.

Authors:  Wei-Qiang Tang; Bao-Ke Hou
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

7.  Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment.

Authors:  Giuseppe Lo Giudice; Valentina de Belvis; Marco Tavolato; Alessandro Galan
Journal:  Clin Ophthalmol       Date:  2011-03-14

8.  Transpupillary thermotherapy for atypical central serous chorioretinopathy.

Authors:  Ryosuke Kawamura; Hidenao Ideta; Hideyuki Hori; Kenya Yuki; Tsuyoshi Uno; Tatsurou Tanabe; Kazuo Tsubota; Tsutomu Kawasaki
Journal:  Clin Ophthalmol       Date:  2012-01-25

9.  A Novel Method for Mouse Retinal Temperature Determination Based on ERG Photoresponses.

Authors:  Marja Pitkänen; Ossi Kaikkonen; Ari Koskelainen
Journal:  Ann Biomed Eng       Date:  2017-06-15       Impact factor: 3.934

10.  Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System.

Authors:  Wenqiang Liu; Anessa Puskar Tawakol; Kayla M Rudeen; William F Mieler; Jennifer J Kang-Mieler
Journal:  Transl Vis Sci Technol       Date:  2020-10-13       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.